BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan L, Xing Z, Guo Z, Fang Z, Jiao W, Guo X, Xu Z, Fang Z, Holmberg A, Nilsson S, Liu Z. Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy. PLoS One 2013;8:e55790. [PMID: 23409045 DOI: 10.1371/journal.pone.0055790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Tonry C, Finn S, Armstrong J, Pennington SR. Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management. Clin Proteomics 2020;17:41. [PMID: 33292167 DOI: 10.1186/s12014-020-09305-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
2 Parolia A, Venalainen E, Xue H, Mather R, Lin D, Wu R, Pucci P, Rogalski J, Evans JR, Feng F, Collins CC, Wang Y, Crea F. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Mol Oncol 2019;13:1121-36. [PMID: 30776192 DOI: 10.1002/1878-0261.12471] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
3 Ning P, Zhong J, Jiang F, Zhang Y, Zhao J, Tian F, Li W. Role of protein S in castration-resistant prostate cancer-like cells. Endocrine-Related Cancer 2016;23:595-607. [DOI: 10.1530/erc-16-0126] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
4 Guo Z, Xing Z, Cheng X, Fang Z, Jiang C, Su J, Zhou Z, Xu Z, Holmberg A, Nilsson S, Liu Z. Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation. PLoS One 2015;10:e0124292. [PMID: 26010447 DOI: 10.1371/journal.pone.0124292] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo Z, Hu X, Xing Z, Xing R, Lv R, Cheng X, Su J, Zhou Z, Xu Z, Nilsson S, Liu Z. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway. Mol Cell Biochem 2015;406:111-9. [PMID: 25957503 DOI: 10.1007/s11010-015-2429-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
6 Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, Guo Z, Guo X, Wang W, Jiao W, Xu Z, Liu Z. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One 2013;8:e62823. [PMID: 23690956 DOI: 10.1371/journal.pone.0062823] [Cited by in Crossref: 90] [Cited by in F6Publishing: 89] [Article Influence: 10.0] [Reference Citation Analysis]